108 related articles for article (PubMed ID: 23553062)
1. Cancer prevalence estimates in Europe at the beginning of 2000.
Gatta G; Mallone S; van der Zwan JM; Trama A; Siesling S; Capocaccia R;
Ann Oncol; 2013 Jun; 24(6):1660-6. PubMed ID: 23553062
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
3. Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project.
Mallone S; De Angelis R; van der Zwan JM; Trama A; Siesling S; Gatta G; Capocaccia R;
Cancer Epidemiol; 2013 Dec; 37(6):850-6. PubMed ID: 24050903
[TBL] [Abstract][Full Text] [Related]
4. Cancer prevalence in Central Europe: the EUROPREVAL Study.
Lutz JM; Francisci S; Mugno E; Usel M; Pompe-Kirn V; Coebergh JW; Bieslka-Lasota M;
Ann Oncol; 2003 Feb; 14(2):313-22. PubMed ID: 12562661
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
AIRTUM Working Group
Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
[TBL] [Abstract][Full Text] [Related]
6. Cancer prevalence in Northern Europe: the EUROPREVAL study.
Möller T; Anderson H; Aareleid T; Hakulinen T; Storm H; Tryggvadottir L; Corazziari I; Mugno E;
Ann Oncol; 2003 Jun; 14(6):946-57. PubMed ID: 12796034
[TBL] [Abstract][Full Text] [Related]
7. Cancer prevalence in European registry areas.
Micheli A; Mugno E; Krogh V; Quinn MJ; Coleman M; Hakulinen T; Gatta G; Berrino F; Capocaccia R;
Ann Oncol; 2002 Jun; 13(6):840-65. PubMed ID: 12123330
[TBL] [Abstract][Full Text] [Related]
8. Cancer prevalence in the UK: results from the EUROPREVAL study.
Forman D; Stockton D; Møller H; Quinn M; Babb P; De Angelis R; Micheli A
Ann Oncol; 2003 Apr; 14(4):648-54. PubMed ID: 12649115
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020.
Guzzinati S; Virdone S; De Angelis R; Panato C; Buzzoni C; Capocaccia R; Francisci S; Gigli A; Zorzi M; Tagliabue G; Serraino D; Falcini F; Casella C; Russo AG; Stracci F; Caruso B; Michiara M; Caiazzo AL; Castaing M; Ferretti S; Mangone L; Rudisi G; Sensi F; Mazzoleni G; Pannozzo F; Tumino R; Fusco M; Ricci P; Gola G; Giacomin A; Tisano F; Candela G; Fanetti AC; Pala F; Sardo AS; Rugge M; Botta L; Dal Maso L
BMC Cancer; 2018 Feb; 18(1):169. PubMed ID: 29426306
[TBL] [Abstract][Full Text] [Related]
11. Rare cancers are not so rare: the rare cancer burden in Europe.
Gatta G; van der Zwan JM; Casali PG; Siesling S; Dei Tos AP; Kunkler I; Otter R; Licitra L; Mallone S; Tavilla A; Trama A; Capocaccia R;
Eur J Cancer; 2011 Nov; 47(17):2493-511. PubMed ID: 22033323
[TBL] [Abstract][Full Text] [Related]
12. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.
Black RJ; Bray F; Ferlay J; Parkin DM
Eur J Cancer; 1997 Jun; 33(7):1075-107. PubMed ID: 9376190
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.
Ferlay J; Colombet M; Soerjomataram I; Dyba T; Randi G; Bettio M; Gavin A; Visser O; Bray F
Eur J Cancer; 2018 Nov; 103():356-387. PubMed ID: 30100160
[TBL] [Abstract][Full Text] [Related]
14. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers.
Dyba T; Randi G; Bray F; Martos C; Giusti F; Nicholson N; Gavin A; Flego M; Neamtiu L; Dimitrova N; Negrão Carvalho R; Ferlay J; Bettio M
Eur J Cancer; 2021 Nov; 157():308-347. PubMed ID: 34560371
[TBL] [Abstract][Full Text] [Related]
15. Cancer prevalence by phase of care: an indicator for assessing health service needs.
Gigli A; Francisci S; Guzzinati S; Hall A; Hachey M; Scoppa S; Mariotto A
Tumori; 2021 Aug; 107(4):311-317. PubMed ID: 33095121
[TBL] [Abstract][Full Text] [Related]
16. The European Cancer Observatory: A new data resource.
Steliarova-Foucher E; O'Callaghan M; Ferlay J; Masuyer E; Rosso S; Forman D; Bray F; Comber H
Eur J Cancer; 2015 Jun; 51(9):1131-43. PubMed ID: 24569102
[TBL] [Abstract][Full Text] [Related]
17. A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain.
Verdecchia A; Micheli A; Colonna M; Moreno V; Izarzugaza MI; Paci E;
Ann Oncol; 2002 Jul; 13(7):1128-39. PubMed ID: 12176794
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of rare cancers and inequalities in oncologic outcomes.
Gatta G; Trama A; Capocaccia R;
Eur J Surg Oncol; 2019 Jan; 45(1):3-11. PubMed ID: 29032924
[TBL] [Abstract][Full Text] [Related]
19. Estimates of cancer incidence and mortality in Europe in 1995.
Bray F; Sankila R; Ferlay J; Parkin DM
Eur J Cancer; 2002 Jan; 38(1):99-166. PubMed ID: 11750846
[TBL] [Abstract][Full Text] [Related]
20. Measuring cancer prevalence in Europe: the EUROPREVAL project.
Capocaccia R; Colonna M; Corazziari I; De Angelis R; Francisci S; Micheli A; Mugno E;
Ann Oncol; 2002 Jun; 13(6):831-9. PubMed ID: 12123329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
